Jue Wang
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A pharmacokinetic study of four bone-protective compounds after oral administration of WSZG extract in primary breast cancer mice.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 17, 2025
Predicting prospective therapeutic targets of Bombyx batryticatus for managing diabetic kidney disease through network pharmacology analysis.
Journal: Medicine
Published: September 17, 2024
Development of cyclopeptide inhibitors specifically disrupting FXR-coactivator interaction in the intestine as a novel therapeutic strategy for MASH.
Journal: Life metabolism
Published: August 27, 2024
A new method for vascular age estimation based on relative risk difference in vascular aging.
Journal: Computers in biology and medicine
Published: November 24, 2023
Breath volatile organic compounds for chronic kidney disease progression monitoring.
Journal: The Analyst
Published: November 13, 2023
Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 30, 2023
Ootheca mantidis mitigates renal fibrosis in mice by the suppression of apoptosis via increasing the gut microbe Akkermansia muciniphila and modulating glutamine metabolism.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 01, 2023
Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 06, 2022
Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1.
Journal: Frontiers in endocrinology
Published: April 11, 2022
Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.
Journal: BMC complementary medicine and therapies
Published: February 26, 2022
Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction.
Journal: Frontiers in pharmacology
Published: January 27, 2022
Last Updated: 09/26/2026